Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02467465
Other study ID # Univ. Complutense de Madrid
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 2014
Est. completion date May 2016

Study information

Verified date July 2020
Source Universidad Complutense de Madrid
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The plantar fasciitis (PF) is the most common cause of pain on the underside of the heel. About 10% to 20% of the population suffer once during their lifetime. PF concept began to describe at the end of XX century through the discovery of new clinical and histopathological signs of the plantar fascia. The difficulty of diagnosis, understanding and treatment of PF require us to develop new treatment avenues to improve the approach and the understanding of it. Dry needling (DN) as a treatment of myofascial pain syndrome (MPS) and myofascial trigger points (MTP) of muscle associated with the pathology, it may be a good treatment strategy, as demonstrated in the treatment of MPS in other body regions such as the neck, shoulder or the lumbar spine.


Description:

Hypothesis:

Add dry needling to a physiotherapy intervention, increases the efficacy of treatment for plantar fasciosis.

Objectives:

General:

Test the efficacy of DN in addition to physiotherapy treatment includes: manual therapy and home exercises; directed to normalize muscle tone and inhibit MTP of the gastrocnemius and soleus muscles, in a group of patients who have been diagnosed with PF.

The variables to measure the efficacy are:

Pain assessment in the affected heel, by visual analog scale (VAS). Ultrasonographic assessment of the thickness of the plantar fascia affected, in longitudinal view, compared with the contralateral.

Goniometric assessment of joint range of ankle dorsiflexion, compared with the contralateral.

Specific:

Analyze the efficacy of the combination of DN treatment with manual therapy and home exercise, in patients who have been diagnosed with PF through monitoring and comparison between groups.

Methodology:

Type of study: clinical trial.

Sample:

It has been used sample size calculator GRANMO version 7.12, and accepting an alpha risk of 0.05 and a beta risk of 0.2, 15 subjects were required in the first group and 15 in the second to detect a difference equal to or greater than 0.6 units. It is assumed that the common standard deviation is 0.57. It has been estimated loss rate of 0%.

population: patients with a confirmed diagnosis of PF, who agree to participate in the study after signing the informed consent and carry out the selection criteria.

Sample:

It has been used sample size calculator GRANMO version 7.12, and accepting an alpha risk of 0.05 and a beta risk of 0.2, 15 subjects were required in the first group and 15 in the second to detect a difference equal to or greater than 0.6 units. It is assumed that the common standard deviation is 0.57. It has been estimated loss rate of 0%.

Selection criteria:

Ultrasonographic study in which a proximal thickened affected plantar fascia is observed greater than or equal to 4 mm.

Pain fell to the first steps in the morning. Pain with palpation at the insertion of the medial calcaneal tubercle, above 5, in a 10-point VAS.

Pathology time evolution of greater than or equal to 4 weeks. Age of patients over 18 years. Acceptance by the patient to participate in the study, having signed the informed consent.

Absence of neoplastic disease. Absence of neurological, sensory, orthopedic and / or surgical alterations. The patient is already doing treatment of physical medicine and rehabilitation. Be subjected to antiplatelet drug therapy. Fear of needles (needle phobia). Difficulty for the patient to understand the instructions to be followed during the study.

Methods of collecting information:

Personal data for each patient and relevant to the study, collected in a protocolized questionnaire, as well as an Excel sheet. All this in a personal history, encoded according to a table of alphanumeric equivalents, allowing subsequent statistical analysis with SPSS19.0 program.

Statistical method:

Initially, a descriptive statistical analysis will be conducted: qualitative variables were summarized by frequency distribution and quantitative by its average and standard deviation. Also it summarizes the information graphically using box plots, bar charts and pie charts.

Furthermore an inferential analysis using parametric or non-parametric techniques, particularly for the main objective analysis of variance was used in two groups (assuming a normal distribution for the variable response) U test or Mann-Whitney will be made in the case lack of normal. To study the response variables in each test group the Student t test or unimuestral averages Wilcoxon signed ranks for related samples was used.

For the analysis of qualitative variables the test of Chi-square test and the association between quantitative variables will be analyzed using the Pearson correlation coefficients and Spearman.

To test these significant differences in values of p <0.05 was assumed. Statistical analysis was performed using the statistical software SPSS v19.0


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date May 2016
Est. primary completion date April 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Ultrasonographic study in which a proximal thickened affected plantar fascia is observed -greater than or equal to 4 mm.

- Pain fell to the first steps in the morning.

- Pain with palpation at the insertion of the medial calcaneal tubercle, above 5, in a 10-point VAS.

- Pathology time evolution of greater than or equal to 4 weeks.

- Age of patients over 18 years.

- Acceptance by the patient to participate in the study, having signed the informed consent.

Exclusion Criteria:

- Presence of neoplastic disease.

- Presence of neurological, sensory, orthopedic and / or surgical alterations.

- The patient is already doing treatment of physical medicine and rehabilitation.

- Be subjected to antiplatelet drug therapy.

- Fear of needles (needle phobia).

- Difficulty for the patient to understand the instructions to be followed during the study.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Physical therapy modalities
Massage, movilization of ankle dorsiflexion and improve flexibility with stretching of calf muscles.
Device:
Invasive Physical therapy modalities
Dry needling added to massage, movilization of ankle dorsiflexion and improve flexibility with stretching of calf muscles.

Locations

Country Name City State
Spain Clínica Universitaria de Podología de la Universidad Complutense de Madrid Madrid

Sponsors (1)

Lead Sponsor Collaborator
Universidad Complutense de Madrid

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View. Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken. 1 day.
Primary Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View. Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken. 1 month
Primary Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View. Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken. 3 month
Primary Ultrasonographic Evaluation of the Thickness of the Affected Plantar Fascia, in Longitudinal View. Plantar fascia thickness in millimeters with ultrasonography at 0,5 centimeters from the calcaneo bone. Mean of 3 measures was taken. 6 month
Secondary Pain Assessment in the Affected Heel, by Visual Analog Scale. First step pain measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 1 day.
Secondary Pain Assessment in the Affected Heel, by Visual Analog Scale. First step pain measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 1 month
Secondary Pain Assessment in the Affected Heel, by Visual Analog Scale. First step pain measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 3 month
Secondary Pain Assessment in the Affected Heel, by Visual Analog Scale. First step pain measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 6 month
Secondary Pain Assessment in the Affected Heel After Long Periods of Rest, by Visual Analog Scale. Pain after long periods of rest measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 1 day
Secondary Pain Assessment in the Affected Heel After Long Periods of Rest, by Visual Analog Scale. Pain after long periods of rest measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 1 month
Secondary Pain Assessment in the Affected Heel After Long Periods of Rest, by Visual Analog Scale. Pain after long periods of rest measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 3 month
Secondary Pain Assessment in the Affected Heel After Long Periods of Rest, by Visual Analog Scale. Pain after long periods of rest measured by Visual Analogue Scale, from 0 to 10 points, in the affected heel. In the Visual Analogue Scale, 0 represents the lowest score and 10 represents the highest score when the patient felt the maximum level of pain. 6 month
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Extended. Range of motion of ankle dorsiflexion with knee extended measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 1 day
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Extended. Range of motion of ankle dorsiflexion with knee extended measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values.Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 1 month
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Extened. Range of motion of ankle dorsiflexion with knee extended measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 3 month
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Extended. Range of motion of ankle dorsiflexion with knee extended measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 6 month
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Flexed. Range of motion of ankle dorsiflexion with knee flexed 90º measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 1 day
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Flexed. Range of motion of ankle dorsiflexion with knee flexed 90º measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 1 month
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Flexed. Range of motion of ankle dorsiflexion with knee flexed 90º measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 3 month
Secondary Goniometric Assessment of Joint Range of Motion Ankle Dorsiflexion With Knee Flexed. Range of motion of ankle dorsiflexion with knee flexed 90º measured in grades using a goniometer. There is not exist minimum and maximum scores for the goniometric assessment, because the limits of the range of motion depends on the joint mobility, then, for this measure, higher values are better results than lower values. Clinically, it means that one patient with 100 degrees of range of motion has more mobility than another with 90 degrees. 6 month
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02982226 - ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis N/A
Completed NCT04022070 - The Effect of Dynamic Tape ® on Plantar Fascitis N/A
Completed NCT04664712 - Efficacy of Focused Shock Waves Combined With Adjuvant Therapy With Tendon Supplement N/A
Completed NCT01439932 - Effectiveness of Manual Therapy Combined With Standard Treatment in the Management of Plantar Fasciitis N/A
Completed NCT02679521 - Radial Extracorporeal Shock Wave Treatment for Chronic Plantar Fasciopathy N/A
Completed NCT05153993 - Effect of Stretching on Visco-elastic Behaviour of the Fascia Plantaris in a Healthy Population N/A
Completed NCT01297686 - Exercise Versus Corticosteroid Randomized Clinical Trial for Plantar Fasciitis Phase 2/Phase 3
Completed NCT04917406 - Effect of Iontophoresis vs. Ultrasound and Iontophoresis in Plantar Fasciitis". Plantar Fasciitis" N/A
Completed NCT02427191 - Micronized dHACM Injectable for the Treatment of Plantar Fasciitis Phase 2/Phase 3
Recruiting NCT06305507 - Differents Laser Applications on Plantar Fasciitis
Completed NCT01429883 - Extracorporeal Shock Wave Treatment - Can the Pain be Reduced? Phase 4
Completed NCT03414268 - Micronized dHACM Injectable for the Treatment of Plantar Fasciitis Phase 3
Completed NCT03020693 - Effectiveness of Invasive Electrostimulation Combined With an Exercise Program in Plantar Fasciitis N/A
Recruiting NCT02668510 - RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort N/A
Completed NCT01865734 - Comparison of Usual Podiatric Care and Early Physical Therapy for Plantar Heel Pain N/A
Recruiting NCT05925777 - Plantar Fasciitis Treatment: Influence of the Possible Presence of Subchondral Bone Edema N/A
Not yet recruiting NCT06370741 - Effect of Stretching Exercises on Plantar Fascia N/A
Recruiting NCT06426667 - Effect of Radiofrequency Treatment in Plantar Fasciitis Patients
Completed NCT05328700 - Effectiveness of Neuromuscular Kinesiology Taping in Plantar Fasciitis N/A
Not yet recruiting NCT06318910 - Customized Foot Orthoses on Muscle Activity During Standing and Gait in Plantar Heel Pain N/A